Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Diğer sürümleri göster (1)

OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the...

Detaylı Bibliyografya
Asıl Yazarlar:	Yeo, T, Dos Passos, GR, Muhammed, L, Everett, R, Reeve, S, Messina, S, Probert, F, Leite, MI, Jacqueline Palace
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley 2020

Benzer Materyaller

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
Yazar:: Tianrong Yeo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Yazar:: Jurynczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Yazar:: Jurynczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Yazar:: Maciej Jurynczyk, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
Yazar:: Jurynczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
Yazar:: Waters, P, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
Yazar:: Elsone, L, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
Yazar:: Juryńczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
Yazar:: Messina, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Yazar:: Sato, D, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Yazar:: Kezuka, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

No strong HLA association with MOG antibody disease in the UK population
Yazar:: Grant-Peters, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
Yazar:: Jae-Won Hyun, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

International multicenter examination of MOG antibody assays
Yazar:: Reindl, M, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
Yazar:: Hacohen, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

No strong HLA association with MOG antibody disease in the UK population
Yazar:: Melissa Grant‐Peters, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
Yazar:: V. E. Avdeeva, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Disease course and disability outcomes in MOG-antibody disease in the UK
Yazar:: Jurynczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
Yazar:: Chuan-bin Sun
Baskı/Yayın Bilgisi: (2023-11-01)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
Yazar:: Jurynczyk, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
Yazar:: Lin Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON
Yazar:: Hao Kang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
Yazar:: Elisabeth Maillart, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
Yazar:: Luca Bollo, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
Yazar:: Chuanbin Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
Yazar:: Xuelian Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
Yazar:: Xuelian Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
Yazar:: Bing-Yan Ren, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
Yazar:: Sotaro Mori, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
Yazar:: Chenyang Gao, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

We need to talk about MOG
Yazar:: Waters, P, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
Yazar:: Pace, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Yazar:: Jarius, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Yazar:: Whittam, DH, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

MOG antibody associated disorder (MOGAD)
Yazar:: Lilley Kate, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Epilepsy in patients with MOG antibody disease
Yazar:: Varvara E. Avdeeva, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
Yazar:: Elena H. Martinez-Lapiscina, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
Yazar:: Omar Al Jassem, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

The Role of Peripheral CNS‐Directed Antibodies in Promoting Inflammatory CNS Demyelination
Yazar:: Silke Kinzel, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Atypical inflammatory demyelinating syndromes of the CNS
Yazar:: Hardy, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)